Alexey V. Protopopov - Publications

Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: May 27, 2026

Long-Term Clinical Outcomes of High-Risk Plaques with Negative fractional flow reserve: the PECTUS-obs study.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: May 27, 2026

Clinical safety and performance of a biodegradable polymer-coated sirolimus-eluting stent in an all-comers population: results from the S-FLEX Russia registry.

Journal: AsiaIntervention

Published: July 12, 2024

High-risk plaques in non-culprit lesions and clinical outcome after NSTEMI vs. STEMI.

Journal: European heart journal. Cardiovascular Imaging

Published: June 04, 2024

Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction.

Journal: Atherosclerosis

Published: June 04, 2024

Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trial.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: March 21, 2024

Fractional Flow Reserve-Negative High-Risk Plaques and Clinical Outcomes After Myocardial Infarction.

Journal: JAMA cardiology

Published: September 13, 2023

True Efficacy of LAA Closure: Patient Outcomes on Long-term Single-Antiplatelet or No Therapy: Insights From the EWOLUTION Registry.

Journal: The Journal of invasive cardiology

Published: May 02, 2022

Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs study.

Journal: BMJ open

Published: July 08, 2021

Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Published: September 21, 2020

Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: December 05, 2019

Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.

Journal: Circulation. Arrhythmia and electrophysiology

Published: April 04, 2019